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Z y x in  c o n t a i n s  a  p r o l i n e - r i c h  N - t e r m i n a l  d o m a i n  t h a t  
i s  s i m i l a r  t o  t h e  C - t e r m i n a l  d o m a i n  i n  t h e  A c tA  p r o t e i n  
o f  t h e  b a c t e r i a ,  L i s t e r i a  m o n o c y t o g e n e s .  W e  s c r e e n e d  t h e  
e n t i r e  a m i n o  a c i d  s e q u e n c e  o f  h u m a n  z y x in  f o r  M e n a -  
i n t e r a c t i n g  p e p t i d e s  a n d  f o u n d  t h a t ,  a s  w i t h  A c tA , 
p r o l i n e - r i c h  s e q u e n c e s  w e r e  t h e  s o l e  z y x in  s e q u e n c e s  
c a p a b l e  o f  b i n d i n g  t o  E n a / v a s o d i l a t o r - s t i m u l a t e d  p h o s ­
p h o p r o t e i n  (V A S P ) f a m i ly  m e m b e r s  i n  v i t r o .  F r o m  t h i s  
i n f o r m a t i o n ,  w e  t e s t e d  z y x in  m u t a n t s  i n  w h i c h  t h e  p r o ­
l i n e - r i c h  s e q u e n c e s  w e r e  a l t e r e d .  T h e  r e d u c t i o n  i n  
M e n a /V A S P  b i n d i n g  w a s  c o n f i r m e d  b y  p e p t i d e  t e s t s ,  im -  
m u n o p r e c i p i t a t i o n ,  a n d  e c t o p i c  e x p r e s s i o n  o f  z y x in  
v a r i a n t s  a t  t h e  s u r f a c e  o f  m i t o c h o n d r i a .  B y  t r a n s f e c t i o n  
a s s a y s  w e  s h o w e d  t h a t  z y x in  i n t e r a c t i o n  w i t h  M e n a /  
V A S P  in  v i v o  e n h a n c e s  t h e  p r o d u c t i o n  o f  a c t i n - r i c h  
s t r u c t u r e s  a t  t h e  a p i c a l  s u r f a c e  o f  c e l l s .  M i c r o in j e c t io n  
i n t o  c e l l s  o f  p e p t i d e s  c o r r e s p o n d i n g  t o  t h e  f i r s t  p r o l in e -  
r i c h  s e q u e n c e  o f  z y x in  c a u s e d  t h e  l o s s  o f  M e n a /V A S P  
f r o m  f o c a l  c o n t a c t s .  F u r t h e r m o r e ,  t h e s e  p e p t i d e s  r e ­
d u c e d  t h e  d e g r e e  o f  s p r e a d i n g  o f  c e l l s  r e p l a t e d  a f t e r  
t r y p s i n i z a t i o n .  W e  c o n c l u d e  t h a t  z y x in  a n d  p r o t e i n s  t h a t  
h a r b o r  s i m i l a r  p r o l i n e - r i c h  r e p e a t s  c o n t r i b u t e  t o  t h e  
p o s i t i o n i n g  o f  M e n a /V A S P  p r o t e i n s .  T h e  p o s i t i o n i n g  o f  
E n a /V A S P  f a m i ly  m e m b e r s  a p p e a r s  t o  b e  i m p o r t a n t  
w h e n  t h e  a c t i n  c y to s k e l e t o n  i s  r e o r g a n i z e d ,  s u c h  a s  d u r ­
i n g  s p r e a d i n g .
Analysis of the hum an actin cytoskeleton has been greatly 
aided by the study of a  bacterial pathogen, Listeria monocyto­
genes Cl, 2). Listeria  en ter cells and then recruit actin mono­
m ers to the ir surface, enabling them  to form F-actin-rich “com­
ets” and move (3-5). The organization of F-actin w ithin the 
comet and the generation of force a t  the interface between the 
bacterial surface and comet is strikingly sim ilar to w hat occurs 
in actin-rich structures of hum an cells, such as the leading edge 
of the lamellipodia (6-8). Because of th is property, Listeria  has
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been very instructive in  identifying proteins th a t function in 
the organization of the actin cytoskeleton of m am m alian cells.
One protein whose characterization has been aided by study 
of Listeria is hum an zyxin. Zyxin is the prototype of a  new 
family of proteins th a t is located a t actin-rich sites in  cells of 
higher eucaryotes (9, 10). By sequence analysis, other hum an 
zyxin-like proteins have been identified, such as the LIM-con- 
taining lipoma preferred partner (LPP)1 (11, 12) and the thy­
roid receptor-interacting protein-6 (13, 14). The hallm ark of 
zyxin and related proteins is an N-term inal domain th a t is rich 
in prolines followed by 3 LIM domains (15, 16). The 380-amino 
acid proline-rich domain of zyxin has several biochemical and 
cell biological properties in common w ith the proline-rich do­
m ain of Listeria ActA (17,18). ActA is a  Listeria  surface protein 
th a t is essential for its motility (19, 20). I t is composed of an 
N-term inal domain th a t interacts w ith the Arp2/3 complex to 
generate actin nucleating activity (21) followed by a large pro­
line-rich domain th a t is believed to be im portant for accelerat­
ing the ra te  of actin assembly (22-24). The sequence sim ilarity 
between zyxin and ActA has prompted studies on their func­
tional sim ilarities.
S im ilarities between the proline-rich domains of zyxin and 
ActA have been confirmed by dem onstrating the presence of 
common epitopes and by performing cell transfection assays 
th a t showed sim ilar effects of the two proteins on cell behavior 
(17, 18). In  addition, both ActA and zyxin bind to members of 
the Ena/vasodilator-stim ulated phosphoprotein (VASP) family 
of proteins (25-28). In Listeria-infected cells, VASP and Mena 
(mam malian ena) are located a t the site of actin polymerization 
on the bacteria (25, 27). In cultured m am m alian cells, VASP is 
located a t focal adhesions and the distal edge of lamellipodial 
extensions (9, 29, 30). VASP is implicated in  the control of 
cytoskeletal organization because it binds F-actin (31, 32) and 
profilin, a 14-kDa protein th a t forms complexes w ith G-actin 
and regulates actin dynamics (33-35). In the case of Listeria 
movement, disruption of the interaction between ActA and 
VASP resu lts in  Listeria m u tan ts th a t move more slowly (23, 
24). Reconstitution of Listeria movement in vitro w ith purified 
proteins has shown th a t although VASP is not absolutely es­
sential for motility, it increases the ra te  of bacterial movement 
(36). The significance of the interaction between zyxin and the 
Ena/VASP family of proteins has not been directly explored in 
m am m alian cells.
Much of w hat is postulated regarding the function of the 
proline-rich region of zyxin arises by analogy to studies of ActA 
and has not been tested  explicitly for zyxin (10). Therefore, we
1 The abbreviations used are: LPP. LIM-containing lipoma preferred 
partner; VASP. vasodilator-stimulated phosphoprotein; GST. glutathi­
one S-transferase; F1TC. fluorescein isothiocyanate; BSA. bovine serum 
albumin; zyx. Zyxin; Nt-Wt. N-terminal 1—380 amino acids of wild-type 
zyxin.



















have characterized the interaction of Mena/VASP proteins with 
zyxin by precise mapping of the amino acids required for bind­
ing and by testing  the consequences for the cell when this 
interaction is disrupted. M utation of one to four key phenylala­
nine residues in the Ena/VASP-binding sites of zyxin progres­
sively abrogates its ability to bind these partners in  vivo. In 
tests in  which we place zyxin a t the plasm a membrane, we find 
th a t the presence of VASP- and Mena-binding sites promotes 
the production of actin-rich structures. In addition, we show 
th a t peptides corresponding to the amino acid sequences re ­
quired for Mena/VASP interaction w ith zyxin disturb the sub- 
cellular distribution of Mena and VASP and inhibit the ra te  of 
cell spreading on fibronectin. O ur results support the hypoth­
esis th a t zyxin makes a critical contribution to the correct 
subcellular distribution of M ena and VASP and th a t th is in te r­
action might be im portant for the restructuring of the actin 
cytoskeleton.
EXPERIMENTAL PROCEDURES
Synthetic Peptides—Peptides were synthesized and purified at the 
University of Utah core facility or by Genosys (TX). Peptides were 
synthesized with an N-terminal cysteine. Lyophilized peptides were 
resuspended in sterile phosphate-buffered saline, and the pH was ad­
justed to 7.5 when necessary. Peptide stocks were prepared at a con­
centration of 20 (120 mM) or 0.2 mg/ml (1.2 mM) and stored in aliquots 
at -2 0  °C until needed. The sequence of the Zyx-(67-81)-peptide is 
PPEDFPLPPPPLAGD, and the sequence of the Zyx-(67-81)-F71A pep­
tide is PPEDAPLPPPPLAGD.
Protein B inding Studies and SPOTs Analysis—Protein binding stud­
ies were performed using a bacterially expressed GST fusion protein 
containing amino acids 6-170 of the N terminus of Mena (kindly sup­
plied by Frank Gertler), which includes the EVH1 domain (GST-Mena- 
(6-170)) (27) that was radiolabeled with 32P using bovine heart muscle 
kinase (Sigma). Labeled GST-Mena-(6-170) was used to probe the 
SPOTs membrane using a modified blot overlay procedure. Autoradiog­
raphy was performed at -8 0  °C using an intensifying screen. Quanti­
tative analysis of protein binding was performed using a Phosphorlm- 
ager and ImageQuant software (Molecular Dynamics, CA).
Analysis of GST-Mena-(6-170) binding to zyxin was determined 
using a custom-made peptide library (SPOTs) conjugated to a cellulose 
membrane (37); this SPOTs membrane was generously provided by 
Jurgen Wehland (Braunschweig, Germany). The library consisted of 
187 overlapping peptides of 15 amino acids in length that spanned the 
complete human zyxin protein sequence. Adjacent peptides shared a 
12-amino acid sequence overlap. A second SPOTs membrane (Genosys) 
was used to determine the effect of amino acid substitution for pheny­
lalanine on EVH1 domain binding to the proline-rich repeats of zyxin. 
The membrane contained three series of overlapping 15-amino acid 
peptides corresponding to the first three proline-rich repeats in zyxin 
and three corresponding series of peptides in which the amino acid 
substitution had been made.
Construction and Expression o f Zyxin M utants—The human zyxin 
sequence was cloned into the pAlterl vector (Promega), and mutagen­
esis reactions were performed using reagents and protocols contained in 
the Altered Sites II in vitro mutagenesis kit. Amino acid substitution of 
alanine for phenylalanine at positions 71, 93, 104, and 114 in human 
zyxin were constructed using mutagenic oligonucleotides that produced 
a codon change from phenylalanine to alanine. Deletion mutants were 
constructed using mutagenic oligonucleotides that spanned sequences 
5' and 3' of the deleted nucleotides. The deleted codons were those for 
amino acids 69-79 inclusive (Al) and amino acids 91-101 inclusive 
(A2). Mutagenesis reactions were verified by sequence analysis. Frag­
ments containing the mutated sequences in human zyxin were intro­
duced by substitution into the NcoVBglW  site of a eucaryotic expression 
vector containing the N-terminal 380 amino acids of zyxin, except for 
Nt-zyxin (F71A/F93A/F104A/F114A) (17). The expressed zyxin was 
tagged at the C terminus with the epitope for the mouse 9E10 anti-Myc 
antibody, followed by 18 amino acids containing the CAAX membrane- 
targeting motif of k-Ras (38). For expression of zyxin a t the mitochon­
dria, DNA encoding the zyxin Nt domain was placed in frame with the 
membrane anchor sequence of ActA (39).
HeLa cells were transfected by calcium phosphate DNA precipitation 
(40). Immunoblotting with anti-Myc antibody was used to confirm ex­
pression of zyxin constructs. Extracts were prepared as described (41), 
and epitope-tagged zyxin and associated proteins were immunoprecipi­
tated from cell lysates with the anti-Myc antibody. Protein mixtures 
were separated by SDS-polyacrylamide gel electrophoresis, transferred 
to nitrocellulose, and analyzed by immunoblotting with anti-VASP or 
anti-Mena antibodies.
In experiments designed to determine the ability of zyxin mutants to 
effect the cytoskeletal changes previously shown to be caused by mem­
brane targeting of zyxin, DNA constructs expressing zyxin variants 
were introduced into HeLa and NIH3T3 cells by transient transfection. 
Following transfection, cells were fixed and processed for fluorescent 
double labeling. The actin cytoskeleton was visualized using rhodam- 
ine-phalloidin (Molecular Probes, OR). Expressed membrane-targeted 
zyxin was localized by indirect immunofluorescence using monoclonal 
antibodies against the Myc tag, followed by FITC-conjugated secondary 
antibodies. At least 100 cells were counted for each case, in three 
separate experiments. Data are reported as percentage ± 1 S.D.
Microinjection Experiments—Potoo tridactylis kidney (PtK2) epithe­
lial cells were plated onto glass coverslips 18 -36 h prior to microinjec­
tion and grown in Dulbecco’s modified Eagle’s medium containing 10% 
fetal calf serum and 2% penicillin/streptomycin. Cells were injected 
using an Eppendorf micromanipulator. The peptide concentration in 
the injection needle was 0.6 mM. FITC-BSA was co-injected with pep­
tides in experiments where cells were also examined by 
immunofluorescence.
Cell Spreading Experiments—PtK2 cells were grown to 80-90% con­
fluence in 100-mm dishes. Cells were trypsinized, washed, and resus­
pended in sterile phosphate-buffered saline plus 10 mM MgCL at a 
concentration of 2.5 x 10s cells/ml. 0.1 mg/ml of Mr 3000 Texas Red- 
dextran (Molecular Probes, OR) was added to the cell suspension to 
serve as a marker for introduction of peptides into cells. Peptides were 
present a t a concentration of 0.4 mM. 0.5 ml of cell suspension was 
placed in 2-mm gap cuvettes and electroporated using a Electrocell 
Manipulator 600 (BTX Inc., San Diego). Cells were placed on ice for 15 
min following electroporation, washed, and plated onto fibronectin- 
coated coverslips. At 1.5 and 3 h after plating, cells were fixed and 
stained using FITC-phalloidin (Molecular Probes). Cells were photo­
graphed using a Zeiss Axiophot, and the developed negatives were 
scanned using Adobe Photoshop software, and cell areas were deter­
mined for a population of cells using NIH Image software. Data are 
reported as the mean area ± S.E. 150-200 cell area measurements 
were determined for each time point.
Microscopy—Immunofluorescence analysis of injected cells was per­
formed after a 10 -min recovery period at 37 °C. Cells were fixed with 3% 
paraformaldehyde and permeabilized with 0.2% Triton X-100. Primary 
antibodies used for immunofluorescence were the B38 anti-zyxin serum 
(15), an anti-Mena serum (27), and a mouse anti-VASP antibody 
(Transduction Laboratories, KY). Secondary antibodies used were 
Texas Red goat anti-rabbit IgG, FITC goat anti-rabbit IgG, and Texas 
Red goat anti-mouse IgG; Texas Red-phalloidin was used to visualize 
F-actin (Molecular Probes). Cells were photographed using a Zeiss 
Axiophot, and developed negatives were scanned and processed by 
Adobe Photoshop software.
RESULTS
The EVH1 Domain o f Mena Interacts with Proline-rich Se­
quences in  the N-term inal Region o f H um an Zyxin—We were 
interested in  probing the physiological significance of the abil­
ity of zyxin to bind Ena/VASP proteins. Therefore, as a first 
step, we have mapped precisely the sites in zyxin th a t bind to 
the N-term inal EVH1 domain of Mena. It was shown previ­
ously th a t zyxin displays several proline-rich sequences sim ilar 
to those in Listeria  ActA th a t serve as docking sites for E na/ 
VASP family of proteins (18). However, i t  was not clear if these 
were the sole sites in  zyxin th a t had the capacity to bind these 
proteins. Since our goal was to compromise the ability of zyxin 
to bind Ena/VASP family of proteins and to explore the physi­
ological consequences of th is interaction, we precisely mapped 
the zyxin amino acid sequences capable of binding GST-Mena- 
(6-170) using a SPOTs custom-synthesized peptide library of 
187 peptides th a t spanned the entire hum an zyxin sequence. 
Each peptide was 15 amino acids in length, and adjacent pep­
tides shared a 12-amino acid sequence overlap. This library 
was probed using radiolabeled, recom binant GST-M ena-(6- 
170), which contains the Mena EVH1 domain. GST-M ena-(6- 



















Fig. t. SPOTs analysis o f GST-Mena-(6-170) b ind ing  to hum an  
zyxin pep tide  sequences. A, schematic drawing of the four proline- 
rich repeats in zyxin is shown. Amino acid sequences are given in C. B, 
GST-Mena-(6-170) interacts with proline-rich sequences of zyxin. 32P- 
Labeled GST-Mena-(6- l  70) was used to probe a library of zyxin-derived 
peptides and found to interact most prominently with four series of 
peptides containing proline-rich sequences. The peptides on the grid are 
identified by their column (1—25) and row (A H) position. C, the se­
quences and alignment of these groups of GST-Mena-(6-170)-interact- 
ing peptides are shown. D, zyxin peptides vary in their binding to 
GST-Mena-(6-170). The degree of binding to GST-Mena-(6-170) was 
determined by Phosphorlmager analysis. The signal obtained with the 
peptide Zyx-(67-81) (A23) in zyxin was defined as 100% of maximal 
binding. The grid position number on the SPOTs membrane and the 
amino acid numbers are shown. E, the conserved phenylalanine residue 
in the zyxin proline-rich motifs is required for EnaA;rASP protein bind­
ing activity. A membrane-conjugated peptide array containing the first 
series of zyxin peptides, Zyx-(64-78), A22; Zyx-(67-81), A23; Zyx-(70- 
84), A24, and complementary peptides in which a phenylalanine resi­
dues at position 71 had been replaced with alanine (marked with an 
asterisk) were tested for GST-Mena-(6-170) binding. Substitution of 
phenylalanine by alanine resulted in a complete loss of binding activity 
for all peptides.
1, A and B ). These peptides correspond to the so-called “proline- 
rich” sequences in  the N-term inal region of zyxin th a t had been 
shown previously to bind Ena/VASP family of proteins and th a t 
share high degree of sim ilarity w ith EVH1 domain binding 
sequences in  ActA (18). Phosphorlm ager analysis was used to 
quantita te  the am ount of GST-Mena-(6^170) bound to each 
peptide sequence (Fig. 1C). The first proline-rich sequence of 
zyxin, specifically the peptide th a t spanned amino acids 67-81 
(Fig. 1, A and B, spot A 23 ), showed the highest degree of 
binding to GST-Mena-(6-170). Binding of GST-Mena-(6-170) 
to the fourth proline-rich m otif which spanned amino acids 
109-123 (Fig. 1, A and B, spot B12) was considerably weaker, 
although, as described later, still significant.
The zyxin peptide sequences identified by GST-M ena-(6-
Fig. 2. C ytoplasm ic zyxin v a rian ts  th a t lack  th e  firs t tw o p ro ­
line-rich  reg ions fail to  d isp lace VASP from  focal adhesions. A,
HeLa cells were transfected with zyxin variants composed of the N- 
terminal 380 amino acids of zyxin with a Myc-tag (NtWt) or zyxin in 
which the proline-rich regions 69-79 and 91-101 were deleted 
UWA/A2). Extracts were analyzed by immunoblotting with anti-Mye 
antibody. NM 1 A2 migrates faster in gels than would be predicted by the 
absence of 22 amino acids. B, HeLa cells expressing either the N- 
terminal 380 amino acids of zyxin (N tW t, B and C) or zyxin in which the 
proline-rich regions 69-79 and 91-101 were deleted UVfA/A2, D and E) 
were analyzed by immunofluorescence microscopy for zyxin production 
(B and D) and VASP localization (C and E). In cells tha t express 
NtAlA2, VASP staining was retained at focal adhesions (E), as in 
untransfected cells (see arrow, C), whereas in cells tha t express the N 
terminus of zyxin with proline-rich regions intact, VASP staining is 
displaced (C).
170) binding contained a phenylalanine residue which, in  the 
case of ActA, had been shown to be essential for VASP and 
Mena binding (18). We tested the significance of th is pheny­
lalanine in  the interaction between zyxin-derived peptides and 
GST-Mena-(6-170) by preparing a m em brane in  which the 
conserved phenylalanine residues in  peptides A22-24, B5, 6, 9, 
and 10 were replaced by alanine. Consistent w ith w hat was 
shown for ActA (18), th is substitution resulted in  a loss of 
GST-Mena-(6-170) binding to the zyxin-derived peptides (Fig. 
IE  and data not shown). Im portantly, no other EV Hl-binding 
sites were detected in zyxin. The comprehensive characteriza­
tion of the Ena/VASP-binding sites in zyxin has enabled us to 
probe the significance of the Mena/VASP binding capacity of 
zyxin in vivo.
M utations That Affect the Proline-rich Repeats in Zyxin D is­
turb Mena and VASP B inding to Zyxin in Vivo—The N-term i­
nal domain of zyxin has previously been shown to be sufficient 
for interaction w ith Mena and VASP in overlay assays (17). 
Here we have examined the effects of altering the proline-rich 
region of zyxin in vivo. Site-directed m utagenesis was used to 
construct a zyxin plasmid (NtAlA2) encoding the N-term inal 
domain of zyxin in which amino acids 69-79  and 91-101 were 
deleted. The NtAlA2 plasmid encodes a protein product th a t 
lacks the first two proline-rich sequences th a t together consti­
tu te  nearly  70% of the Mena binding capacity th a t we observed. 
Expression constructs encoding the wild-type N-term inal do­
m ain of zyxin (NtWt) or NtAlA2 zyxin were introduced into 
cells by transien t transfection, and protein expression was 
confirmed by im m unoblotting (Fig. 2A). Both proteins were 
produced in  sim ilar am ounts. Consistent w ith the reduction in 
proline content, the NtAlA2 species m igrated faster on gels 
than  the unmodified N t version (15).
If the proline repeats of zyxin play a central role in  docking 
Ena/VASP family members, we predicted th a t the production 
of a zyxin varian t th a t failed to localize to adhesion plaques 
would act as a dom inant negative version of zyxin th a t would 
recruit Ena/VASP family members away from the ir normal 
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Fig. 3. S u bstitu tion  of conserved  pheny la lan ines in  zyxin re ­
duces M ena b ind ing  in  vivo. A, the N-terminal domain (380 amino 
acids,I of zyxin in frame with a Myc epitope tag (lane 1, N tW t) and 
variants harboring phenylalanine to alanine mutations (lane 2, F71A; 
lane 3. F93A; lane 4. F71.93A; lane 5. F71.93.104A) were expressed by 
transient transfection in HeLa cells. Extracts were examined by immu­
noblotting with anti-Myc antibody to confirm protein levels. B, NtWt 
zyxin and Nt(F-A) variants were isolated by immunoprecipitation with 
anti-Myc antibodies. The immunoprecipitates were then analyzed for 
the presence of Mena by immunoblotting with anti-Mena antiserum. A 
relatively strong Mena signal was detected in the NtWt zyxin (lane 1) 
sample. Mutation of phenylalanine 71 (lane 2) or 93 (lane 3) resulted in 
a reduced Mena binding, whereas alteration of both phenylalanine 71 
and 93 (lane 4) or 71. 93. and 104 (lane 5) reduced Mena binding to 
levels below detection.
expression of Nt-zyxin, which fails to accumulate in adhesion 
plaques (Fig. 2B ), results in a loss of VASP from these sites 
(Fig. 2 0 .  In contrast, VASP rem ained concentrated a t focal 
adhesions in cells producing the NtAlA2 zyxin varian t th a t 
lacks two of the proline repeats (Fig. 2D). These resu lts confirm 
th a t the proline-rich repeats present in zyxin are im portant for 
interaction with an Ena/VASP family member in vivo.
We further tested the importance of the proline-rich repeats 
of zyxin for its interaction with Ena/VASP family members in  
vivo by immunoprecipitation. We showed previously th a t ta r ­
geting zyxin to the inner leaflet of the plasm a membrane, via 
the addition of a C-term inal CAAY sequence from the protein 
k-Ras, resulted in changes in actin assembly and organization 
(17). Based on the findings with the SPOTs m em brane with 
zyxin (Fig. 1) and w ith ActA (18), we made site-specific m u ta­
tions th a t resulted in  the substitution of phenylalanine resi­
dues a t positions 71, 93, 104, and 114 w ithin the proline-rich 
Ena/VASP-docking sites. These substitutions were introduced 
into a construct engineered for the expression of the first 380 
amino acids of zyxin, as well as a C-term inal Myc epitope tag  
and a CAAY sequence. Immunoprecipitation experiments 
showed th a t Mena exists in a complex with the zyxin varian t 
containing unaltered proline-rich sequences (Fig. 3). S ubstitu­
tion of alanine a t position 71 of the first proline-rich sequence 
or a t position 93 in the second proline-rich sequence resulted in 
a reduction in M ena association with zyxin. M utant proteins in 
which two (F71A/F93A) or three (F71A/F93A/F104A) substitu ­
tions were made showed very little binding of Mena by im m u­
noblotting. Thus, the degree of Mena interaction w ith zyxin 
depended on the num ber of unaltered proline-rich repeats in 
zyxin. S im ilar resu lts were obtained when these zyxin m utants 
were tested for the ir ability to in teract w ith VASP (data not 
shown).
To explore further the importance of zyxin proline-rich se­
quences for docking of Ena/VASP proteins, we examined the 
interaction between VASP and wild-type zyxin or zyxin Phe-
Fio. 4. All fo u r EVH1 b ind ing  dom ains m ust be m u ta ted  in 
o rd e r  to  d is ru p t zyxin VASP binding. HeLa cells were transiently 
transfected with cDNAs encoding zvxin Nterm-Mito or zvxin Nterm- 
Mito F71A/F93A/F104A/F114A. The" protein products contain a mem­
brane anchor domain of ActA. which causes them to localize at the 
surface of mitochondria. Cells were double-stained with anti-zvxin (A 
and C) and anti-VASP (B and D) antibodies. The VASP protein was 
recruited to the mitochondria bv wild-tvpe zvxin N terminus but not 
zyxin N-terminal F71A/F93A/F104A/F114A. see arrows. Note that in 
the absence of VASP recruitment to the mitochondria. VASP staining at 
focal adhesion plaques is more intense (£>).
Ala varian ts in cells by ectopically expressing zyxin a t the 
surface of mitochondria. This method perm its the examination 
of protein assemblages by immunofluorescence and has been 
previously applied to ActA, zyxin, and a zyxin-related protein, 
LPP (39, 42, 43). As expected, expression of zyxin N t a t the 
mitochondria resulted in accumulation of VASP a t these or­
ganelles (Fig. 4, A  and B). Interestingly, even when the triple 
m u tan t (F71A/F93A/F104A) was expressed, VASP staining 
could still be detected in association w ith the mitochondria, 
although the staining was weaker than  when wild-type zyxin 
sequences were utilized (data not shown). However, when we 
expressed Nt-zyxin (F71A/F93A/F104A/F114A) in  which all 
EV Hl-binding sites were altered, VASP staining was no longer 
detected a t the mitochondria (Fig. 4, C and D). These results 
reveal th a t the EV Hl-binding site containing the Phe-114 is 
likely active in  vivo, despite th a t it gave the w eakest signal by 
SPOTS analysis and did not recruit sufficient Mena or VASP 
for detection by W estern blotting. For th is analysis, it was clear 
th a t in order to te s t the significance of zyxin binding with 
Ena/VASP members it was necessary to m utate all four pro­
line-rich sites.
The Effects upon the Actin Cytoskeleton Induced by Mem- 
brane-targetecl Zyxin Can Be Separated into VASP-dependent 
and VASP-inclepenclent Types—We tested the role of E na/ 
VASP members in producing these rearrangem ents by express- 
in g th e  N -term inal zyxin (F71A/F93A/F104A/F114A) m utan t in 
which all Ena/VASP-docking sites were compromised. In HeLa 
cells expressing the unaltered  m em brane-targeted Nt-zyxin, 
endogenous stress fibers were disrupted, and the cells p re­
sented a homogenous F-actin staining as had been previously 
reported (Fig. 5, A and B) (17). Somewhat surprisingly, we 
observed alterations in the actin cytoskeleton upon expression 
of the m em brane-targeted N-term inal zyxin (F71A/F93A/ 
F104A/F114A) m utant, even when all four Ena/VASP-binding 
sites are compromised (Fig. 5, C and D). As w ith the wild-type 
zyxin, stress fibers were no longer present, and F-actin was 
distributed throughout the cytoplasm. Thus, the N-term inal 
region of zyxin m ust harbor sequences in addition to the E na/ 



















Fig. 5. Zyxin-CAAX-mediated d is ru p tio n  of stress  fibers does 
n o t re q u ire  Ena/VASP-docking sites. HeLa cells were transiently 
transfected with plasmids encoding the N-terminal domain (380 amino 
acids,I of zyxin in frame with a Myc epitope and a OAA.Y membrane- 
targeting motif (NtWt, A  and B) or a variant with phenylalanine to 
alanine mutations (N t(F71,93,104,114A), C and D). Membrane-targeted 
zyxin was detected with an anti-Myc antibody (Zyxin, A  and C). F-actin 
was detected by rhodamine-phalloidin staining (B and D). The absence 
of VASP binding does not affect the ability of zyxin to alter the actin 
cytoskeleton in this manner.
toskeletal reorganization.
Actin-rich Surface Projections Are Enhanced by Nt-zyxin- 
CAAX That Contains Ena/VASP-docking Sites—We further 
explored the importance of the capacity of zyxin to bind Ena/ 
VASP members by comparing the effect of expression of wild- 
type and the N-term inal (F71A/F93A/F104A/F114A) zyxin m u­
ta n t in NIH3T3 cells because these cells produce strik ing actin- 
rich projections a t the apical surface upon zyxin production 
(17). Cells were stained w ith rhodamine-phalloidin to m ark 
F-actin and w ith anti-Myc epitope antibody to detect tran s­
fected cells th a t express m em brane-targeted Nt-zyxin. In these 
cells, actin-rich surface structures were observed in 67% of the 
cells counted (S.D. = 4%). These structures varied in their 
abundance on the surface of a cell; however, to score positive, a t 
least half the apical surface area of the cell had to be covered 
w ith such structures (Fig. 6, A and B). In contrast to the high 
level of surface ruffling observed in cells expressing Nt-zyxin 
CAAX, actin-rich surface projections in cells producing zyxin 
Nt(F71A/F93A/F104A/F114A) were consistently and signifi­
cantly less frequent than  cells producing unaltered zyxin (Fig.
6, C and D). As w ith Nt-zyxin these surface structures were 
still occasionally present in zyxin Nt(F71A/F93A/F104A/ 
F114A)-producing cells; however, they were consistently re­
duced in size and in number, and only in 32% of the cases did 
they cover a t least half of the cell surface (S.D. = 8%). Because 
the presence of docking sites on zyxin for Ena/VASP members 
had an effect upon the actin cytoskeleton, although under a r ­
tificial conditions, we continued to explore the role of E na/ 
VASP members in zyxin-dependent actin cytoskeleton events 
using other methods.
Introduction o f a Zyxin-derived Proline-rich Peptide into 
Cells Ca uses Mislocalization o f Ena I VASP Members and Re­
duces the Degree o f Cell Spreading on Fibronectin—As de­
scribed above, comparison of the effects of m em brane-targeted 
Nt-zyxin and the Nt(F71A/F93A/F104A/F114A) m u tan t form of 
zyxin revealed a role for Ena/VASP binding capacity in the
zyxin-dependent changes in actin assembly and organization 
th a t we observe by employing the CAAX assay. In an effort to 
study the possible importance of the ability of zyxin to associate 
w ith Mena/VASP by a more quantitative method, as the actin 
cytoskeleton is undergoing rearrangem ents, we examined the 
process of cell spreading. We have utilized a zyxin-derived 
peptide, Zyx-(67-81)-(PPEDFPLPPPPLAGD), which corre­
sponds to the amino acid sequence of the first proline-rich 
repeat (spot A23, Fig. LA) and prim ary binding site for E na/ 
VASP family members in zyxin, to inhibit competitively the 
ability of zyxin to dock these proteins in vivo.
F irst we examined the effect of introducing the Zyx-(67—81)- 
peptide into well spread PtK2 cells. As anticipated, the in tro­
duction of the Zyx-(67-81)-peptide into cells by microinjection 
resulted in the reduction of M ena (Fig. 7, A and B) and VASP 
(data not shown) from the ir norm al subcellular locations. In ­
troduction of the Zyx-(67-81)-peptide into cells did not appear 
to affect the subcellular distribution of zyxin (Fig. 6, C and D). 
In contrast, introduction of the Zyx-(67—81)-(F71A) peptide had 
no apparen t effect on M ena localization (Fig. 7, E  and F). These 
results fu rther confirm th a t the Ena/VASP interaction with 
zyxin detected in vitro likely occurs in vivo and is im portant for 
the norm al subcellular distribution of Ena/VASP family of 
proteins.
Once we had confirmed the ability of the Zyx-(67-81)-peptide 
to reduce the am ount of Ena/VASP members from the ir normal 
subcellular location, we examined the effect of perturbing the 
zyxin-Ena/VASP interaction on the process of cell spreading, 
an activity th a t depends on the assembly and reorganization of 
the actin cytoskeleton. The Zyx-(67-81)-peptide or the Zyx- 
(67—81)-(F71A) peptide was mixed w ith Texas Red-dextran (Mr 
3000) to serve as a m arker for uptake and was introduced into 
PtK2 cells in suspension by electroporation. In a  typical exper­
iment, over 90% of the cells examined displayed in ternal Texas 
Red-dextran following electroporation (data not shown). After a 
short recovery period, cells were plated onto fibronectin- coated 
coverslips and allowed to spread. Cells into which the control 
(non-inhibitory) Zyx-(67—81)-(F71A) peptide was introduced 
were well spread by 1.5 h after p lating (Fig. 8A) and achieved 
an average area of 409 fim 2 by 3 h  (Fig. 8 0 .  These cells spread 
a t a  ra te  comparable to cells subjected to the electroporation 
protocol in the absence of peptide (data not shown). In contrast, 
cells into which the Zyx-(67-81)-peptide was introduced dis­
played an average area of only 203 fim 2 by 1.5 h and 260 fim 2 
by 3 h, which represents a 36% reduction in cell area compared 
w ith controls (Fig. 8, B  and C). Since the Zyx-(67-81)-peptides 
have been shown to disrupt the interaction between zyxin and 
Ena/VASP family members, these results suggest th a t this 
interaction is im portant during cell spreading.
DISCUSSION
One strategy for defining the precise role(s) of zyxin in vivo is 
to characterize the functional significance of the ability of zyxin 
to bind to its partners. In th is report, we have focused our 
attention on the interaction of zyxin w ith Ena/VASP family 
members, proteins implicated in actin assembly processes. We 
describe the zyxin amino acid sequences required for binding to 
Mena and VASP, and we examine the consequences of d isrup t­
ing th is interaction in vivo.
We have scanned the entire zyxin amino acid sequence by 
SPOTs analysis using the EVH1 domain of M ena to identify 
sequences capable of binding Ena/VASP family members (27). 
We identified four proline-rich peptides in hum an zyxin th a t 
bind to the EVH1 domain. These regions of zyxin represent the 
sequences th a t exhibit high sim ilarity to the ActA protein of 
Listeria  (18), which have also been nam ed ABM-1 sites (44, 45). 
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Fig. 6. A etin-rieh surface s tru c tu re s  induced  by  Zyxin-CAAX are  enhanced  by th e  p resence  of Ena/VASI’-doeking sites. NIH3T3 
cells were transiently transfected with plasmids encoding the N-terminal domain (380 amino acids,i of zyxin in frame with a Myc epitope and a 
CAAX membrane-targeting motif (NtWt. A andiJj or a variant with phenylalanine to alanine mutations (Nt(F71,93,104,114A), C' and D). In these 
images, the plane of focus is at the apical surface of the cells in order to more clearly see surface structures; the remaining actin cytoskeletal 
structures are outside of the plane of focus. The apical face is shown of NIH3T3 cells expressing Nt-zyxin-CAAX contains many actin-rich 
structures that are also stained for zyxin. Of these cells. 67% display F-actin-rich structures at their surface. These structures were less frequently 
present in cells expressing Nt(F71,93,104,114A) zyxin-C'AAX (C and D) as only 32% of these cells display such structures shown in A. whereas the 
majority of cells display far fewer or smaller actin-filled structures (C). Cell counts were made from the results of three experiments, in which 100 
cells were counted each time. Standard deviations are shown. B ar represents 10 /jxn.
hydrophilic regions th a t are necessary for the interaction with 
the proline-rich sequences, such as those found in ActA and 
zyxin (46). Resolution of EVH1 domain by x-ray crystallo- 
graphic studies confirms the presence of a pocket th a t accepts 
the phenylalanine in proline-rich sequences of zyxin and ActA 
(47, 48).
Because Listeria  ActA and zyxin display four proline-rich- 
binding sites for Ena/VASP, it is possible th a t they have the 
capacity to amplify the local concentration of these proteins. 
Ena/VASP proteins can homo-oligomerize and are thought to 
form tetram ers, thus if each proline repeat could dock a tet- 
ram eric Ena/VASP protein, 16 Ena/VASP monomers would be 
expected to be docked on each fully occupied ActA or zyxin. Our 
results illustrate th a t as the proline repeats of zyxin are com­
promised, less Ena/VASP can be co-immunoprecipitated with 
zyxin. Indeed, by the mitochondria targeting  assay, which is 
more sensitive than  im m unoprecipitation assays, we were able 
to show th a t all four EV Hl-binding sites m ust be altered to 
compromise maximally the interaction between zyxin and 
VASP. However, it should be pointed out th a t the precise molar 
ratio of zyxin to Ena/VASP protein in the complex is not known. 
Although it is clear from studies using the SPOTs m em brane 
and individual zyxin-derived proline-rich peptides th a t these 
short sequences are sufficient to bind Ena/VASP proteins in 
vitro, it is also plausible th a t the zyxin protein m ay coopera­
tively w rap around a single Ena/VASP te tram er w ith each 
proline-rich sequence docking one Ena/VASP monomer. In this 
regard, it is interesting th a t a m utation in Drosophila ena th a t 
results in lethal nervous system disorganization affects the 
ability of the E na protein to homo-oligomerize and to bind zyxin 
(28).
In an effort to evaluate the role of zyxin in binding of E na/ 
VASP family members w ithin living cells, we examined the 
possibility th a t expression of a cytosolic zyxin v arian t would 
cause Ena/VASP members to be displaced from focal adhesions. 
Consistent w ith biochemical findings showing th a t zyxin h a r­
bors m ultiple binding sites for Ena/VASP members (this report
Fig. 7. In jection  of th e  Zyx-(67-81)-peptide in to  cells causes 
th e  m isloealization  of Mena. Cells were injected with a fluorescent 
marker (BSA-FITCJ and either Zyx-(67-81>-peptide or Zyx-(67-81>- 
F71A peptide and were subsequently fixed and prepared for indirect 
immunofluorescence. F1TC-BSA was used as a marker for identification 
of injected cells (B, D, and F). Injection of the Zyx-(67-81)-peptide 
resulted in a strong reduction of Mena a t focal contacts (Mena antibody. 
A). Injection of the Zyx-(67-81)-peptide did not result in zyxin displace­
ment (zyxin antibody. C), indicating that focal contacts were still intact. 
Injection of Zyx-(67~81J-(F71A,) peptide did not result in Mena mislo- 
calization (Mena antibody. E).
ActA protein, the conserved phenylalanine residue serves as a 
critical predictor of Mena-binding capacity (18). Detailed anal­
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Fig. 8. The Zyx-(67-81)-peptide in h ib its  cell sp read ing  on fi­
bronectin . Zyx-67-81-(F71A> peptide (A) or zyx67-81  peptide (B) were 
introduced into cells in suspension by electroporation. Cells were fixed 
and stained with FITC-phalloidin 3 h after plating onto fibronectin- 
coated coverslips. and average cell area was determined. B ar = 25 /uni.
C, the mean area of cells that had taken up Zyx-(67-81)-peptide was 
measured at 1.5 and 3 h after plating. Zyx-(67-81)-peptide-treated cells 
showed a reduction in mean cell area of 36% as compared with cells that 
had taken up Zyx-(67-81)-(F71A) peptide. Mean area ± S.E. (p < 0.001) 
is shown.
and Refs. 18 and 26-28), VASP was lost from focal adhesions of 
transfected cells th a t overproduced the N term inus of zyxin, a 
construct th a t would be expected to compete w ith endogenous 
zyxin for Ena/VASP partners. Overexpression of zyxin 
(NtAlA2), which lacks two of the four proline-rich docking sites 
for Ena/VASP members, does not lead to detectable mislocal- 
ization of VASP. Furtherm ore, the interaction of Ena/VASP 
members w ith zyxin was also disrupted by injection of peptides 
th a t mimic the amino acids 67-81 of zyxin th a t encompass one 
proline-rich sequence. The displacement of Mena and VASP 
from focal adhesions has also been described in experim ents in 
which sim ilar proline-rich peptides derived from ActA se­
quences were injected into cells (18, 27, 39). These results 
illustrate  th a t the interaction between zyxin and Ena/VASP 
family of proteins th a t occurs via the proline rich in  vitro also
occurs in  vivo and is a  property common to th is motif. Genetic 
evidence from studies in Drosophila has revealed th a t m u ta­
tions th a t disturb the ability of E na to bind zyxin, and presum ­
ably adversely affect its proper localization, lead to failure of 
nervous system development (28). I t should be pointed out, 
however, th a t there m ay be other proline-rich ligands th a t 
contribute to the targeting  of Ena/VASP members to particular 
subcellular locations. Indeed, both vinculin and robo have E na/ 
VASP-docking sites (49-52,) and Fyn-binding protein (Fyb/ 
SLAP) has also been identified as a ligand for Ena/VASP pro­
tein in T-cells (53).
Our studies also suggest th a t the placem ent of zyxin within 
a  cell can affect the distribution of the Ena/VASP family of 
proteins. Zyxin targeted to mitochondria, for example, appears 
to recruit VASP proteins away from focal adhesions. Moreover, 
in cells injected w ith the Zyx-(67-81)-peptide, zyxin localiza­
tion rem ained unchanged, revealing th a t zyxin likely directs 
Mena and VASP to F-actin-rich sites ra th e r than  the converse 
possibility th a t M ena or VASP directs zyxin to particular sub­
cellular domains. The ligand th a t directs zyxin to focal adhe­
sions is not yet known. Determ ination of how zyxin is targeted 
to the focal adhesions is likely to be of in te rest for understand­
ing cell motility.
One experim ental system to te st the role of zyxin in cells is 
by transfection assays in which zyxin and zyxin varian ts are 
placed a t the inner leaflet of the plasm a m em brane via an 
in-frame CAAX m otif (17). This approach was used to charac­
terize the functional sim ilarities between the C-term inal do­
m ain of ActA and the N -term inal domain of zyxin, domains 
th a t contain sim ilar proline-rich sequences. Previously we had 
proposed th a t a variety  of actin cytoskeleton defects caused by 
the ectopic expression of the N-term inal domain of zyxin might 
be due to VASP binding. In experim ents in which we tested 
zyxin m utan ts m utated  a t the four EVHl-binding sites, F71A/ 
F93A/F104A/F114A, we were able to separate zyxin-induced 
changes in the actin cytoskeleton th a t were dependent upon 
Ena/VASP docking from those th a t were not. For example, 
disruption of stress fibers and generation of homogenous phal- 
loidin staining did not require Ena/VASP-docking sites, sug­
gesting th a t other zyxin-binding partners m ight be responsible 
for this effect.
In contrast, the CAAX assay had revealed a zyxin-specific 
phenotype, the production of actin-rich structures a t the dorsal 
face of cells. Despite th a t th is is an artificial system for pro­
ducing actin-rich structures, it points toward an Ena/VASP- 
independent role for zyxin in the control of F-actin because cells 
expressing the zyxin m u tan t F71A/F93A/F104A/F114A pro­
duced these structures a t a significantly lower frequency. The 
precise origin of these structures is not known; however, it 
m ight resemble another system in which actin-rich structures 
were produced by receptor-m ediated clustering (54). In th a t 
system by induction of WASP/CDC42 actin-rich filopodia were 
produced and zyxin, and VASP were recruited. We noted th a t 
Ena/VASP binding m ight not be absolutely required for the 
zyxin-induced surface structures; rather, Ena/VASP members 
m ay cooperate w ith other zyxin-binding partners. One candi­
date for involvement in cytoskeletal events th a t require the 
N-term inal domain of zyxin is a-actinin, which binds directly to 
zyxin via a m otif near the N term inus (42, 55, 56).
To examine the interaction of zyxin w ith Ena/VASP family 
members by another approach, we introduced the peptides 
Zyx-(67—81) and Zyx-(67-81)-(F71A) into cells and m easured 
the ir ra te  of spreading after trypsinization. W ith peptides th a t 
represent the first proline-rich repeat of zyxin, bu t not those in 
which a  phenylalanine was substituted for an alanine, we 



















substrate. It is possible th a t by disrupting the delivery of E na/ 
VASP members to zyxin-containing sites, the capacity of a cell 
to generate F-actin a t specific sites m ight also be reduced. 
There are several observations th a t support th is hypothesis. 
During spreading of trypsinized cells, there is a global increase 
in F-actin, including a t the edge of the cell (57, 58). Injection of 
ActA-related peptides, which are very sim ilar to those derived 
from zyxin, will arrest Listeria movement in infected cells (59). 
In addition, the peptides had no effect upon adherent cells in 
which the actin cytoskeleton was a t steady state, as shown 
here, and as has been previously reported for injection of ActA- 
derived peptides (27). Spreading of trypsinized cells m ight offer 
new opportunities to te s t processes th a t require actin 
polymerization.
Proline-rich sequences sim ilar to those found in zyxin are 
also present in proteins such as LPP and vinculin (43, 49, 50); 
therefore, we cannot rule out the possibility th a t mimicking 
peptides would disrupt these interactions as well as th a t of 
zyxin. Recent evidence suggests th a t such a broad approach 
m ight be necessary to detect the consequences of zyxin and 
VASP binding upon cells. In mice in which the VASP gene is 
disrupted, fibroblast cells show no obvious abnorm alities in 
adhesion or m igration (60, 61). It is only in  cells, such as 
platelets from the same anim als where Mena is not expressed, 
th a t significant differences can be detected (60, 61). The possi­
bility of overlapping function between VASP and related pro­
teins is also suggested from studies of transgenic flies in which 
hum an VASP can functionally replace D. ena (28) and from 
experiments in which VASP and M ena can restore Listeria 
movement in  cell-free extracts (32). The observation th a t p la te­
lets aggregate faster in the absence of VASP suggests th a t 
VASP m ight play a role in the inhibition of actin assembly and 
cell-surface extension. This in terpretation  is in contrast to the 
experiments presented here th a t indicate th a t neutralization of 
Mena and VASP inhibits cell spreading. This discrepancy 
m ight reflect the differences in  cell types studied (fibroblasts 
versus platelets) or in experim ental approach (chronic inhibi­
tion with the genetic approach versus tran sien t inhibition with 
the peptide). F urther work will be required to resolve th is 
issue.
Studies of ActA have been im portant in  identifying and char­
acterizing a role for zyxin and Ena/VASP family members in 
eucaryotic cells. We have shown th a t the sequence require­
m ents for zyxin and Ena/VASP interaction are sim ilar to w hat 
had been predicted from studies of the ActA and Ena/VASP 
interaction. By m utating  the critical phenylalanine residue and 
testing the m utan ts in transfection assays, we find th a t there 
are likely other functional sim ilarities between ActA and zyxin 
th a t have yet to be characterized. In addition, we have used 
peptides derived from the sequence of zyxin to perturb  the 
interaction between zyxin and Ena/VASP members in vivo. We 
found th a t cells showed a reduced ability to spread, suggesting 
th a t th is  interaction, perhaps a t a level th a t involves entire 
protein families, may be necessary during cellular events 
where the actin cytoskeleton is remodeled. It will be a chal­
lenge to biologists to characterize the individual contribution of 
each member of these families in the regulation of the actin 
cytoskeleton of m am m alian cells.
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